{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:49:31Z","timestamp":1769273371619,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.taap.2021.115570","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T02:46:06Z","timestamp":1620355566000},"page":"115570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Downregulated expression of intestinal P-glycoprotein in rats with cisplatin-induced acute kidney injury causes amplification of its transport capacity to maintain \u201cgatekeeper\u201d function"],"prefix":"10.1016","volume":"423","author":[{"given":"Fuyo","family":"Takeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115570_bb0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tox.2008.06.009","article-title":"Renal xenobiotic transporters are differentially expressed in mice following cisplatin treatment","volume":"250","author":"Aleksunes","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2021.115570_bb0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2021.115570_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","article-title":"Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug-drug interaction studies","volume":"59","author":"Elmeliegy","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2021.115570_bb0020","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-07-4793","article-title":"Interaction of cisplatin with the human organic cation transporter 2","volume":"14","author":"Filipski","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2021.115570_bb0025","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/cpt.1360","article-title":"Clinical aspects of transporter-mediated drug-drug interactions","volume":"105","author":"Gessner","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2021.115570_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/clpt.2013.86","article-title":"Transporters in drug development and clinical pharmacology","volume":"94","author":"Giacomini","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2021.115570_bb0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2021.115570_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2133\/dmpk.22.67","article-title":"Mechanistic analysis for drug permeation through intestinal membrane","volume":"22","author":"Hayashi","year":"2007","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2021.115570_bb0045","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1021\/mp300178a","article-title":"Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC","volume":"9","author":"Herraez","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.taap.2021.115570_bb0050","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1200\/JCO.2017.74.4789","article-title":"Antiemetics: American society of clinical oncology clinical practice guideline update","volume":"35","author":"Hesketh","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.taap.2021.115570_bb0055","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.semnephrol.2009.07.008","article-title":"Acute kidney injury in the elderly: problems and prospects","volume":"29","author":"Himmelfarb","year":"2009","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.taap.2021.115570_bb0060","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.taap.2021.115570_bb0065","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40266-017-0484-4","article-title":"Drug-induced kidney injury in the elderly","volume":"34","author":"Khan","year":"2017","journal-title":"Drugs Aging"},{"key":"10.1016\/j.taap.2021.115570_bb0070","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cnur.2017.04.007","article-title":"Polypharmacy and medication management in older adults","volume":"52","author":"Kim","year":"2017","journal-title":"Nurs. Clin. North Am."},{"key":"10.1016\/j.taap.2021.115570_bb0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2010.05.027","article-title":"Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance","volume":"395","author":"Kwatra","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.taap.2021.115570_bb0080","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-981-13-7647-4_5","article-title":"Transporter-mediated drug-drug interactions and their significance","volume":"1141","author":"Liu","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.taap.2021.115570_bb0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.47102\/annals-acadmedsg.V38N3p240","article-title":"Drug-induced kidney diseases \u2013 pathology and current concepts","volume":"38","author":"Loh","year":"2009","journal-title":"Ann. Acad. Med. Singap."},{"key":"10.1016\/j.taap.2021.115570_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-13-8871-2_1","article-title":"Prevalence and disease burden of chronic kidney disease","volume":"1165","author":"Lv","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.taap.2021.115570_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40620-017-0392-z","article-title":"Cisplatin nephrotoxicity: a review of the literature","volume":"31","author":"Manohar","year":"2018","journal-title":"J. Nephrol."},{"key":"10.1016\/j.taap.2021.115570_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport-an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.taap.2021.115570_bb0105","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1007\/s11095-008-9668-2","article-title":"Regulation of renal ion transporters in cisplatin-induced acute kidney injury and uremia in rats","volume":"25","author":"Morisaki","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2021.115570_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/17425255.2020.1701653","article-title":"Modulation of expression\/function of intestinal P-glycoprotein under disease states","volume":"16","author":"Murakami","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2021.115570_bb0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0928-0987(00)00113-5","article-title":"Region-dependent disappearance of vinblastine in rat small intestine and characterization of its P-glycoprotein-mediated efflux system","volume":"11","author":"Nakayama","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2021.115570_bb0120","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/jpet.106.112631","article-title":"Down-regulation of intestinal drug transporters in chronic renal failure in rats","volume":"320","author":"Naud","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115570_bb0125","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1039\/C8DT00838H","article-title":"The side effects of platinum-based chemotherapy drugs: a review for chemists","volume":"47","author":"Oun","year":"2018","journal-title":"Dalton Trans."},{"key":"10.1016\/j.taap.2021.115570_bb0130","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/0886022X.2019.1628780","article-title":"Acute toxic kidney injury","volume":"41","author":"Petejova","year":"2019","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.taap.2021.115570_bb0135","doi-asserted-by":"crossref","first-page":"F1513","DOI":"10.1152\/ajprenal.00419.2018","article-title":"Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states","volume":"315","author":"Polichnowski","year":"2018","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.taap.2021.115570_bb0140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/js970163u","article-title":"Involvement of intestinal P-glycoprotein in the restricted absorption of methylprednisolone from rat small intestine","volume":"87","author":"Saitoh","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2021.115570_bb0145","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/0886022X.2019.1602054","article-title":"The prominent impairment of liver\/intestinal cytochrome P450 and intestinal drug transporters in sepsis-induced acute kidney injury over acute and chronic renal ischemia, a mouse model comparison","volume":"41","author":"Sukkummee","year":"2019","journal-title":"Ren. Fail."},{"key":"10.1016\/j.taap.2021.115570_bb0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/jbt.20001","article-title":"Protein expression pattern of P-glycoprotein along the gastrointestinal tract of the Yucatan micropig","volume":"18","author":"Tang","year":"2004","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.taap.2021.115570_bb0155","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2165\/11316640-000000000-00000","article-title":"Cisplatin overdose: toxicities and management","volume":"32","author":"Tsang","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.taap.2021.115570_bb0160","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0009-9236(98)90066-2","article-title":"Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole","volume":"64","author":"Varis","year":"1998","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2021.115570_bb0165","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/aps.2017.54","article-title":"Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2BT and intestinal P-gp","volume":"38","author":"Wang","year":"2017","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21001770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21001770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:54:10Z","timestamp":1758574450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21001770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":33,"alternative-id":["S0041008X21001770"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115570","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulated expression of intestinal P-glycoprotein in rats with cisplatin-induced acute kidney injury causes amplification of its transport capacity to maintain \u201cgatekeeper\u201d function","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115570"}}